Viewing Strategy Training in Children With (Cerebral) Visual Impairment (NCT05600140) | Clinical Trial Compass
RecruitingNot Applicable
Viewing Strategy Training in Children With (Cerebral) Visual Impairment
Netherlands60 participantsStarted 2024-10-25
Plain-language summary
Viewing strategies are strategies used to process visual Information. Many children with visual impairment seem to lack systematic viewing strategies. However, it is unknown how viewing strategies differ between children with normal vision and children with (cerebral) visual impairment. In addition, viewing strategy training is often adopted in clinical practice, but till date there is no scientific evidence about effectiveness of this approach.
The current project has two goals: (1) to measure viewing strategies used by children with normal vision, children with ocular visual impairment and children with CVI, and (2) to evaluate whether training viewing strategies results in more efficiënt visual Information processing.
Who can participate
Age range
5 Years – 12 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria typically developing children with normal vision:
* Age 5-12 years
* linear distant visual acuity of 0.1 logMAR or better
* Verbal IQ above 70
* Absence of developmental disorders or psychiatric problems like ASS or AD(H)D
Inclusion criteria for children with ocular visual impairment:
* Age 5-12 years
* Children with linear distance visual acuity better \<=1.3logMAR and \>0.1 logMAR
* Intact central visual field (at least \> 30 degrees)
* Children with a verbal IQ above 70
* Absence of developmental disorders or psychiatric problems like ASS or AD(H)D
Inclusion criteria for children with cerebral visual impairment:
* Age 5-12 years
* Linear distance visual acuity \<=0.3 logMAR
* Having the diagnosis CVI (verified by ophthalmologists)
* Children with a verbal IQ above 70
* Absence of psychiatric problems like ASS or AD(H)D
Additional inclusion criterion for study 2 (evaluating training effectiveness): children with (cerebral) visual impairment should have an indication for viewing strategy training. Training should not be indicated if children have no problems performing academic tasks (i.e. when speed and accuracy of visual processing is within the normal range). The age range for study 2 is 5-9 years.
Exclusion criteria:
* Children with VI: linear near visual acuity \>1.0 logMAR
* Children with visual field defect \< 30 degrees
* Children with a verbal IQ below 70
* Children who attended a form of vision training in the past two years
* Children wi…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Changes in reading accuracy after viewing strategy training
Timeframe: Group A: Day 0, Month 2, Month 8; group B: Day 0, Month 2, Month 4
2
Changes in reading speed after viewing strategy training
Timeframe: Group A: Day 0, Month 2, Month 8; group B: Day 0, Month 2, Month 4
3
Changes in visual search accuracy after training
Timeframe: Group A: Day 0, Month 2, Month 8; group B: Day 0, Month 2, Month 4
4
Changes in visual search speed after training
Timeframe: Group A: Day 0, Month 2, Month 8; Group B: Day 0, Month 2, Month 4
5
Changes in saccade amplitudes during reading and visual search after training
Timeframe: Group A: Day 0, Month 2, Month 8; Group B: Day 0, Month 2, Month 4
6
Changes in fixation duration during reading and search after training
Timeframe: Group A: Day 0, Month 2, Month 8; Group B: Day 0, Month 2, Month 4